Stay updated on Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says that some content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T15:12:52.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:51:10.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T15:20:09.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    A 403 Forbidden page is displayed, replacing the study content with a minimal header and a Home link, indicating access to the record is blocked.
    Difference
    20%
    Check dated 2026-09-21T22:24:32.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    There are no additions or deletions listed for this study in the provided changes data, so the study record remains unchanged.
    Difference
    0.1%
    Check dated 2026-09-14T18:22:29.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added dates 2026-09-01, 2025-12-31, and 2026-08-28; removed 2026-08-26, 2026-03-05, and 2026-08-24 from the Study Record Dates, reflecting updates to the record’s milestone and revision history.
    Difference
    0.3%
    Check dated 2026-09-07T19:37:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page.